期刊文献+

妊娠高血压综合征与孕前体重指数的关系研究 被引量:2

下载PDF
导出
摘要 目的:探讨妊娠高血压综合征与孕前体重指数的关系。方法:回顾性分析我院分娩产妇中妊娠高血压综合征患者的临床资料,以探讨妊娠高血压患者孕前BMI与PIH发生的关系。结果:产妇的PIH发病率随着BMI值的升高而升高;其中BMI<18.5kg/m2产妇的PIH发病率为10.91%;BMI=18.5~22.9kg/m2产妇的PIH发病率为11.50%;BMI=23.0~24.9kg/m2产妇的PIH发病率为16.52%;BMI≥25.0kg/m2产妇的PIH发病率为25.00%,不同BMI值产妇的PIH发病率有明显差异(P<0.05)。另外,轻度和中度PIH发病率均随着BMI的增加而升高(P<0.05)。BMI≥23.0kg/m2的重度PIH发病率高于BMI23.0~24.9kg/m2组,BMI18.5-22.9kg/m2组和BMI<18.5kg/m2组(P<0.05)。结论:在临床和保健中应首先了解孕前的BMI,确定孕妇是属于消瘦、理想或肥胖型体质,密切监测孕期体重增长,并给予相应营养指导,以期减少妊高征的发生,提高孕期保健质量。
作者 林琳
出处 《中国民族民间医药》 2010年第18期23-23,共1页 Chinese Journal of Ethnomedicine and Ethnopharmacy
  • 相关文献

参考文献3

二级参考文献15

  • 1谭玉洁,范子田,杨慧霞.尾加压素Ⅱ基因多态性与妊娠期糖尿病遗传易感性的关系[J].中华妇产科杂志,2006,41(11):732-735. 被引量:8
  • 2Simonet WS, Lacey DL, Cunstan CR, et al. Osetoprotegerin:a novel secreted protein involved in the regulation of bone density. Cell, 1997,89:303 -319.
  • 3Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol, 2002,22:549- 553.
  • 4Hong JS, Santolaya-Forgas J, Romero R, et al. Maternal plasma osteoprotegerin concentration in normal pregnancy. Am J Obstet Gynecol, 2005,193:1011-1015.
  • 5Alvarez L, Peris P, Guanabens N, et al. Serum osteoprotagerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bispbosphonates. Arthritis Rheum, 2003,48:824-828.
  • 6Yano K, Shibata O, Mizuno A, et al. Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) : possible role of OPG/OCIF in the prevention of osteoporosis in pregnancy. Biochem Biophys Res Commun, 2001,288:217-224.
  • 7Touyz RM, Schiffrin EL Tyrosine kinase signaling pathways modulate angiotensin Ⅱ-induced calcium transients in vascular smooth muscle cells. Hypertension, 1996,27 : 1097-1103.
  • 8Loneran M, Aponso D, Marvin KW, et al. Tumor necrosis factorrelated apoptosis-inducing ligand ( TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm. J Clin Endocrinol Metab, 2003,88:3835-3844.
  • 9Martin T J, Gillespie MT. Receptor activator of nuclear factor kappa B ligand (RANKL): another link between breast and bone. Trends Endocrinol Metab, 2001,12:2-4.
  • 10Balat O, Aksoy F, Kutlar I, et al. Increased plasma levels of Urotensin-Ⅱ in preeclampsia-eclampsia: a new mediator in pathogenesis? Eur J Obstet Gynecol Reprod Biol, 2005, 120: 33.

共引文献10

同被引文献17

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部